YOKNEAM, Israel, May 4 /PRNewswire/ -- Lumenis(R) Ltd., a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced today that it has signed a three-year exclusive sales and distribution agreement with the Fasel Group for the sale of Aluma Skin Renewal Systems with its revolutionary FACES(TM) (Functional Aspiration Controlled Electrothermal Stimulation) technology. Under the terms of the agreement, Fasel agrees to purchase from Lumenis a minimum of 175 Aluma Skin Renewal Systems by the end of 2008 to maintain exclusivity in Italy. Currently expanding their operations, Fasel is one of the largest aesthetic and medical products distributors in Italy. Both Lumenis and Fasel hope to exceed this minimum volume of 175 Aluma Skin Renewal Systems.
"The combination of Lumenis' superior technology and Aluma's competitive advantages, together with Fasel's excellent aesthetic market knowledge and accessibility, is the perfect launch pad to introduce and develop the market for RF devices in Italy. We are pleased that Fasel recognizes the unique capabilities of Lumenis' Aluma system over others and the significant market potential. And we look forward to a long and cooperative relationship between our companies," commented Amnon Harari, Vice President of European Sales and Service. "We believe that this agreement represents only the first of similar successes in other countries throughout the region."
According to Mrs. Elisabetta Fasani, the CEO of Fasel Group, and Mr. Antonio Ruggeri, the President of Fasel Group, "We have chosen Lumenis because we recognize and value their combination of advanced technology, long-time quality of products and the professional support of Lumenis in Italy. We plan to maintain our leadership in the aesthetic and medical market by adding this new RF technology. We are very confident in the capability of Lumenis technologies to continue increasing our penetration in these markets. With Aluma, we will provide an important solution to the emerging needs of our customers."
About Aluma(TM) Skin Renewal System with FACES(TM)
Lumenis received FDA clearance and launched the Aluma for the treatment of fine lines and wrinkles in October 2005, and currently offers this breakthrough technology as a stand-alone unit and an upgrade module to the popular Lumenis One(TM) platform for the delivery of effective, predictable, and virtually painless results. Aluma's groundbreaking and patent pending FACES technology combines radio frequency energy with vacuum to allow superficial as well as deep dermal heating for effective treatment, with virtually no pain and very low risk of adverse events. The vacuum-assisted bipolar radio frequency handpiece folds the skin and positions it in tight contact with the electrodes, placing the dermis in direct alignment with the energy. Special alignment of the electrodes enables RF energy to meet dermis impedance, which results in a uniform, contained zone of heating for collagen contraction and renewal with little to no discomfort.
About Fasel
Fasel is a leading medical aesthetic organization founded in Italy in 1986 to offer a complete range of services and specialties within the medical-aesthetic sector. Currently, with 1500 clients in Italy, the company continues to expand to meet the needs in the domestic market. Fasel, currently the most advanced medical aesthetic organization in Italy, strives to continually improve its proposals by investing in the most up-to-date technologies. For more information about Fasel and its services, log onto http://www.faselgroup.it
About Lumenis
Lumenis is a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto http://www.lumenis.com
Investors: Lauri Hanover 1-866-232-6803 972-4-959-9122
The statements in this press release that are not historical facts are forward-looking statements which are subject to risks and uncertainties. The Company's actual results could differ materially from those anticipated in the forward looking statements based on a variety of factors, including, among others: uncertainties with respect to market acceptance of the Company's products, the implementation and outcome of our Turnaround Plan, obtaining regulatory approvals for new products or for the sale of existing products in new markets and enforcement of intellectual property rights; risks associated with competition and competitive pricing pressures, economic conditions generally, the Company's international operations and the Company's ability to integrate its operations with those of acquired businesses; the outcome of several securities class action lawsuits to which the Company is subject ; uncertainties relating to the Company's continuing liquidity; uncertainties relating to the Company's lack of audited financial statements and other risks detailed from time to time in the reports filed by Lumenis with the SEC.
Lumenis Ltd.CONTACT: Lauri Hanover of Lumenis Ltd., 1-866-232-6803, +972-4-959-9122
